Financial results - CARDIOMED SRL

Financial Summary - Cardiomed Srl
Unique identification code: 9097536
Registration number: J40/9/1997
Nace: 8622
Sales - Ron
237.299
Net Profit - Ron
155.188
Employee
2
The most important financial indicators for the company Cardiomed Srl - Unique Identification Number 9097536: sales in 2023 was 237.299 euro, registering a net profit of 155.188 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Cardiomed Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 116.731 117.195 141.115 173.537 181.549 195.122 171.834 209.954 221.912 237.299
Total Income - EUR 116.731 117.195 141.544 174.624 256.574 195.122 173.891 210.500 221.916 237.299
Total Expenses - EUR 109.141 113.070 129.204 109.735 165.295 105.168 70.663 85.781 90.701 79.786
Gross Profit/Loss - EUR 7.590 4.125 12.340 64.889 91.278 89.954 103.228 124.719 131.216 157.513
Net Profit/Loss - EUR 4.115 479 7.927 62.797 88.535 88.002 101.638 122.779 129.042 155.188
Employees 2 2 2 2 3 3 3 3 3 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 7.3%, from 221.912 euro in the year 2022, to 237.299 euro in 2023. The Net Profit increased by 26.537 euro, from 129.042 euro in 2022, to 155.188 in the last year.

Check the financial reports for the company - Cardiomed Srl

Rating financiar

Financial Rating -
Cardiomed Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Cardiomed Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Cardiomed Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Cardiomed Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Cardiomed Srl - CUI 9097536

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 40.141 31.928 19.349 14.305 12.384 11.480 9.836 52.263 38.516 22.361
Current Assets 18.223 17.194 25.298 37.429 134.913 79.843 95.190 72.003 92.336 137.538
Inventories 1.004 0 864 306 0 179 0 0 0 0
Receivables 243 195 2.118 662 46.712 60.507 27.889 194 71.203 121.045
Cash 16.977 16.999 22.316 36.461 88.201 19.157 67.301 71.809 21.133 16.494
Shareholders Funds 126.903 128.440 111.965 134.858 159.273 88.053 101.687 122.827 129.018 155.236
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 3.550 5.126 3.332 3.334 7.763 3.270 3.339 1.439 1.834 4.663
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 137.538 euro in 2023 which includes Inventories of 0 euro, Receivables of 121.045 euro and cash availability of 16.494 euro.
The company's Equity was valued at 155.236 euro, while total Liabilities amounted to 4.663 euro. Equity increased by 26.610 euro, from 129.018 euro in 2022, to 155.236 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Cardiomed Srl

Comments - Cardiomed Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.